Bangkok Dusit Medical Services Public Company Limited (BDULF)
For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Bangkok Dusit Medical Services Public Company Limited (BDULF) with AI Score 52/100 (Hold). Bangkok Dusit Medical Services (BDMS) is Thailand's largest private hospital network, operating 47 hospitals across Thailand and Cambodia. Market cap: 0, Sector: Healthcare.
Last analyzed: Mar 17, 2026Bangkok Dusit Medical Services Public Company Limited (BDULF) Healthcare & Pipeline Overview
Bangkok Dusit Medical Services (BDMS) is a leading healthcare provider in Thailand and Cambodia, operating a network of hospitals and offering diverse medical services, wellness programs, and pharmaceutical products, with a focus on both local and international patients and a strong dividend yield of 5.29%.
Investment Thesis
Bangkok Dusit Medical Services presents a compelling investment case based on its dominant market position in Thailand's private healthcare sector. The company's extensive network of 47 hospitals and diverse service offerings cater to a broad patient base, driving consistent revenue. A profit margin of 14.2% and a gross margin of 36.1% demonstrate financial stability. The dividend yield of 5.29% offers an attractive return for investors. Growth catalysts include increasing medical tourism to Thailand, expansion of specialized medical services, and strategic investments in related healthcare businesses. However, potential risks include regulatory changes in the healthcare industry and economic fluctuations in Thailand and Cambodia.
Based on FMP financials and quantitative analysis
Key Highlights
- Market capitalization of $10.49 billion, reflecting its strong position in the healthcare sector.
- P/E ratio of 18.95, indicating a reasonable valuation compared to earnings.
- Profit margin of 14.2%, showcasing efficient operations and profitability.
- Gross margin of 36.1%, demonstrating effective cost management in service delivery.
- Dividend yield of 5.29%, providing a substantial income stream for investors.
Competitors & Peers
Strengths
- Largest private hospital network in Thailand.
- Comprehensive range of medical services.
- Strong brand reputation.
- Established medical tourism business.
Weaknesses
- Reliance on the Thai economy.
- Exposure to regulatory changes in the healthcare industry.
- Competition from other hospital groups.
- Potential impact from global health crises.
Catalysts
- Ongoing: Increasing medical tourism to Thailand, driven by affordable and high-quality healthcare services.
- Ongoing: Expansion of specialized medical services, such as cardiology and oncology, to attract more patients.
- Ongoing: Strategic investments in healthcare technology to improve efficiency and patient outcomes.
Risks
- Potential: Economic downturns in Thailand and Cambodia, which could reduce demand for healthcare services.
- Potential: Increased competition from local and international hospital groups.
- Potential: Changes in government healthcare policies that could impact revenue and profitability.
- Ongoing: Fluctuations in currency exchange rates, which could affect the cost of imported medical equipment and supplies.
Growth Opportunities
- Expansion of Medical Tourism Services: Thailand is a well-known hub for medical tourism. BDMS can capitalize on this by enhancing its services for international patients, including specialized packages, multilingual support, and partnerships with international insurance providers. The global medical tourism market is projected to reach $272.7 billion by 2027, offering a substantial growth opportunity for BDMS.
- Development of Specialized Medical Centers: BDMS can further develop specialized medical centers focusing on high-demand areas such as cardiology, oncology, and orthopedics. These centers can attract both local and international patients seeking advanced treatments and specialized expertise. The market for specialized medical services is growing rapidly, driven by technological advancements and increasing prevalence of chronic diseases.
- Strategic Investments in Healthcare Technology: Investing in advanced healthcare technologies, such as telemedicine, AI-powered diagnostics, and robotic surgery, can improve efficiency, enhance patient outcomes, and attract tech-savvy patients. The global telemedicine market is projected to reach $41.4 billion by 2026, presenting a significant opportunity for BDMS to integrate technology into its service offerings.
- Expansion into Wellness and Preventive Care: BDMS can expand its focus on wellness and preventive care services, including health screenings, personalized wellness programs, and lifestyle coaching. This can attract a broader customer base and generate recurring revenue streams. The global wellness market is estimated at over $4.7 trillion, indicating a substantial opportunity for BDMS to capitalize on the growing demand for wellness services.
- Geographic Expansion within Southeast Asia: While BDMS already has a presence in Cambodia, further geographic expansion within Southeast Asia can tap into new markets and diversify revenue streams. Countries like Vietnam, Myanmar, and Laos offer significant growth potential due to their rapidly growing economies and increasing demand for quality healthcare services. Strategic partnerships and acquisitions can facilitate this expansion.
Opportunities
- Expansion into new geographic markets within Southeast Asia.
- Development of specialized medical centers.
- Investment in healthcare technology.
- Growth in wellness and preventive care services.
Threats
- Economic downturns in Thailand and Cambodia.
- Increased competition from local and international providers.
- Changes in government healthcare policies.
- Fluctuations in currency exchange rates.
Competitive Advantages
- Extensive network of hospitals providing broad geographic coverage.
- Strong brand reputation and recognition in Thailand and Southeast Asia.
- Comprehensive range of medical services catering to diverse patient needs.
- Established relationships with local and international insurance providers.
About BDULF
Bangkok Dusit Medical Services Public Company Limited (BDMS), established in 1969 and headquartered in Bangkok, Thailand, is the largest private hospital network in Thailand. The company operates 47 hospitals in Thailand and Cambodia, managing them under six primary hospital groups: Bangkok Hospital Group, Samitivej Hospital Group, BNH Hospital, Phyathai Hospital Group, Paolo Hospital Group, and Royal Hospital Group. These groups provide a comprehensive range of medical services, from general medical care to specialized treatments, catering to both local and international patients. BDMS has expanded its services beyond traditional hospital care to include holistic clinical wellness programs, hotels, and restaurants. The company also sells health and cosmetic products and provides various support services such as accounting, health insurance, laboratory services, investment, information technology, training, skin and aesthetics telemedicine, genome sequencing, insurance brokerage, air medical transportation, facility management, property management services, and asset management services. Furthermore, BDMS is involved in manufacturing and distributing medicine and pharmaceutical products, along with e-commerce and real estate ventures, diversifying its revenue streams and solidifying its position as a comprehensive healthcare provider in the region.
What They Do
- Operates a network of 47 hospitals in Thailand and Cambodia.
- Provides a wide range of medical services, including general and specialized treatments.
- Offers holistic clinical wellness programs.
- Sells health and cosmetic products.
- Provides accounting, health insurance, and laboratory services.
- Offers telemedicine and genome sequencing services.
- Manufactures and distributes medicine and pharmaceutical products.
Business Model
- Generates revenue from hospital services, including inpatient and outpatient care.
- Earns income from wellness programs and related health services.
- Sells pharmaceutical products and medical supplies.
- Provides support services such as health insurance and laboratory testing.
Industry Context
Bangkok Dusit Medical Services operates within the growing healthcare industry in Southeast Asia, driven by increasing affluence, aging populations, and rising demand for quality medical services. Thailand is a popular destination for medical tourism, attracting patients from around the world seeking affordable and high-quality treatments. The competitive landscape includes both local and international hospital groups. BDMS differentiates itself through its extensive network, comprehensive service offerings, and strong brand reputation. The industry is expected to continue growing, driven by both domestic and international demand.
Key Customers
- Local Thai patients seeking general and specialized medical care.
- International patients seeking medical tourism services.
- Corporations and organizations providing health benefits to their employees.
- Individuals seeking wellness and preventive care services.
Financials
Chart & Info
Bangkok Dusit Medical Services Public Company Limited (BDULF) stock price: Price data unavailable
Latest News
No recent news available for BDULF.
Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for BDULF.
Price Targets
Wall Street price target analysis for BDULF.
MoonshotScore
What does this score mean?
The MoonshotScore rates BDULF's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Poramaporn Prasarttong-Osoth
CEO
Poramaporn Prasarttong-Osoth is the Chief Executive Officer of Bangkok Dusit Medical Services Public Company Limited. Details regarding her early career and educational background are not available in the provided source data. However, as CEO, she is responsible for leading the strategic direction and overall management of the largest private hospital network in Thailand.
Track Record: Under Poramaporn Prasarttong-Osoth's leadership, Bangkok Dusit Medical Services has maintained its position as the leading healthcare provider in Thailand and has continued to expand its network and services. Specific achievements and milestones during her tenure are not detailed in the provided source data, but the company's consistent financial performance and market leadership suggest a successful track record.
BDULF OTC Market Information
The OTC Other tier, where BDULF trades, represents the lowest tier of the OTC market. Companies in this tier often have limited or no financial disclosure, making it difficult for investors to assess their financial health and operational performance. Unlike companies listed on major exchanges like the NYSE or NASDAQ, OTC Other companies do not have to meet minimum listing standards, such as requirements for market capitalization, share price, and financial reporting. This lack of regulation and oversight increases the risk associated with investing in these companies.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited or no financial disclosure, making it difficult to assess the company's financial health.
- Low trading volume and liquidity, leading to price volatility and difficulty in executing trades.
- Lack of regulatory oversight and minimum listing standards, increasing the risk of fraud or mismanagement.
- Potential for delisting or suspension of trading due to non-compliance with OTC market regulations.
- Higher risk of price manipulation due to the lack of transparency and oversight.
- Verify the company's registration and legal status.
- Attempt to obtain and review any available financial statements, even if unaudited.
- Research the background and experience of the company's management team.
- Assess the company's business model and competitive landscape.
- Understand the risks associated with investing in OTC stocks.
- Monitor trading volume and price activity for any unusual patterns.
- Consult with a financial advisor before making any investment decisions.
- The company has been in operation since 1969, indicating a long history.
- It operates a large network of hospitals in Thailand and Cambodia.
- It is a publicly traded company, even though it's on the OTC market.
- The company has a recognized CEO, Poramaporn Prasarttong-Osoth.
Bangkok Dusit Medical Services Public Company Limited Stock: Key Questions Answered
What does Bangkok Dusit Medical Services Public Company Limited do?
Bangkok Dusit Medical Services (BDMS) is the largest private hospital network in Thailand, operating 47 hospitals across Thailand and Cambodia. It provides a comprehensive range of medical services, from general care to specialized treatments like cardiology and oncology, catering to both local and international patients. Beyond hospital services, BDMS also offers wellness programs, sells health and cosmetic products, and provides support services such as health insurance and laboratory testing, making it a comprehensive healthcare provider in the region.
What do analysts say about BDULF stock?
AI analysis is currently pending for BDULF. Generally, healthcare stocks are evaluated based on factors such as revenue growth, profit margins, and market share. Investors also consider the company's ability to innovate and adapt to changing healthcare trends. BDULF's dividend yield of 5.29% may be an important factor for investors seeking income. Further analysis is needed to provide a comprehensive assessment of the stock's potential.
What are the main risks for BDULF?
The main risks for Bangkok Dusit Medical Services include economic downturns in Thailand and Cambodia, which could reduce demand for healthcare services. Increased competition from local and international hospital groups could also put pressure on revenue and profitability. Changes in government healthcare policies and fluctuations in currency exchange rates are additional factors that could impact the company's performance. As an OTC stock, BDULF carries additional risks related to low liquidity and limited financial disclosure.
What are the key factors to evaluate for BDULF?
Bangkok Dusit Medical Services Public Company Limited (BDULF) currently holds an AI score of 52/100, indicating moderate score. Key strength: Largest private hospital network in Thailand.. Primary risk to monitor: Potential: Economic downturns in Thailand and Cambodia, which could reduce demand for healthcare services.. This is not financial advice.
How frequently does BDULF data refresh on this page?
BDULF prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven BDULF's recent stock price performance?
Recent price movement in Bangkok Dusit Medical Services Public Company Limited (BDULF) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Largest private hospital network in Thailand.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Should investors consider BDULF overvalued or undervalued right now?
Determining whether Bangkok Dusit Medical Services Public Company Limited (BDULF) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.
What research should beginners do before buying BDULF?
Before investing in Bangkok Dusit Medical Services Public Company Limited (BDULF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Financial data is based on the most recent available information.
- OTC analysis is based on general characteristics of the OTC market and may not be specific to BDULF.